List of Genentech patents

Patents where

Current Assignee

Name

Genentech

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture	Patent 8217149 was granted and assigned to Genentech on July, 2012 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	8217149	July 10, 2012
‌ US Patent 7695936 Knobs and holes heteromeric polypeptides	Patent 7695936 was granted and assigned to Genentech on April, 2010 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7695936	April 13, 2010
‌ US Patent 7642228 Method for making heteromultimeric polypeptides	Patent 7642228 was granted and assigned to Genentech on January, 2010 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7642228	January 5, 2010
‌ US Patent 11655305 Treatment of metastatic breast cancer	Patent 11655305 was granted and assigned to Genentech on May, 2023 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	11655305	May 23, 2023
‌ US Patent 7183076 Method for making multispecific antibodies having heteromultimeric and common components	Patent 7183076 was granted and assigned to Genentech on February, 2007 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7183076	February 27, 2007
‌ US Patent 8216805 Knobs and holes heteromeric polypeptides	Patent 8216805 was granted and assigned to Genentech on July, 2012 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	8216805	July 10, 2012
‌ US Patent 7951917 Method for making multispecific antibodies having heteromultimeric and common components	Patent 7951917 was granted and assigned to Genentech on May, 2011 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7951917	May 31, 2011
‌ US Patent 11473151 Diagnostic and therapeutic methods for cancer		Genentech	Genentech	United States Patent and Trademark Office	11473151	October 18, 2022
‌ US Patent 11402382 Diagnostic and therapeutic methods for cancer	Patent 11402382 was granted and assigned to Genentech on August, 2022 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	11402382	August 2, 2022
‌ US Patent 11340199 Systems and methods for two-dimensional chromatography	Patent 11340199 was granted and assigned to Genentech on May, 2022 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	11340199	May 24, 2022
‌ US Patent 7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds	Patent 7608681 was granted and assigned to Genentech on October, 2009 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7608681	October 27, 2009
‌ US Patent 10364268 Ion exchange membrane chromatography	Patent 10364268 was granted and assigned to Genentech on July, 2019 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	10364268	July 30, 2019
‌ US Patent 9968676 Subcutaneous anti-HER2 antibody formulations and uses thereof	Patent 9968676 was granted and assigned to Genentech on May, 2018 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	9968676	May 15, 2018
‌ US Patent 7332581 Polypeptide variants with altered effector function	Patent 7332581 was granted and assigned to Genentech on February, 2008 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7332581	February 19, 2008
‌ US Patent 7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds	Patent 7635749 was granted and assigned to Genentech on December, 2009 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7635749	December 22, 2009
‌ US Patent 7855275 Cysteine engineered antibodies and conjugates	Patent 7855275 was granted and assigned to Genentech on December, 2010 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7855275	December 21, 2010
‌ US Patent 7319006 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7319006 was granted and assigned to Genentech on January, 2008 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7319006	January 15, 2008
‌ US Patent 9345661 Subcutaneous anti-HER2 antibody formulations and uses thereof	Patent 9345661 was granted and assigned to Genentech on May, 2016 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	9345661	May 24, 2016
‌ US Patent 7375078 Heterocyclic self-immolative linkers and conjugates	Patent 7375078 was granted and assigned to Genentech on May, 2008 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7375078	May 20, 2008
‌ US Patent 8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 8414898 was granted and assigned to Genentech on April, 2013 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	8414898	April 9, 2013
‌ US Patent 11523969 Apparatus and methods for sealing a medicament within a medical delivery device	Patent 11523969 was granted and assigned to Genentech on December, 2022 by the United States Patent and Trademark Office.	Genentech	Genentech	United States Patent and Trademark Office	11523969	December 13, 2022
‌ US Patent 7723485 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates	Patent 7723485 was granted and assigned to Genentech on May, 2010 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7723485	May 25, 2010
‌ US Patent 7371826 Polypeptide variants with altered effector function	Patent 7371826 was granted and assigned to Genentech on May, 2008 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7371826	May 13, 2008
‌ US Patent 7785903 Variable domain library and uses	Patent 7785903 was granted and assigned to Genentech on August, 2010 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	7785903	August 31, 2010
‌ US Patent 6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production	Patent 6897294 was granted and assigned to Genentech on May, 2005 by the United States Patent and Trademark Office.		Genentech	United States Patent and Trademark Office	6897294	May 24, 2005

...

Results per page:

1,953 results

0 selected

1,953 results

0 selected